Dendritic Cells in Breast Cancer Patients
Author Information
Author(s): Bella S Della, Gennaro M, Vaccari M, Ferraris C, Nicola S, Riva A, Clerici M, Greco M, Villa M L
Primary Institution: Università degli Studi di Milano
Hypothesis
Breast cancer alters the maturation and function of dendritic cells in patients.
Conclusion
Breast cancer patients have fewer dendritic cells in their blood, which are more mature but less effective at producing important immune signals.
Supporting Evidence
- The number of dendritic cells was significantly lower in breast cancer patients compared to healthy controls.
- Dendritic cells from cancer patients had a more mature phenotype but produced less IL-12.
- Surgical removal of the tumor normalized dendritic cell function.
- Breast cancer patients had a higher frequency of CD34+ cells in their blood.
Takeaway
This study found that people with breast cancer have fewer immune cells called dendritic cells, which help fight cancer, and those they do have don't work as well.
Methodology
Flow cytometry was used to analyze whole-blood samples from breast cancer patients and healthy controls to count and characterize dendritic cells.
Potential Biases
Potential bias due to the selection of patients and controls.
Limitations
The study did not explore the long-term effects of treatment on dendritic cell function.
Participant Demographics
53 patients aged 29–86 years with invasive breast cancer and 68 age- and sex-matched healthy controls.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website